LIFEVANTAGE CORP Gain (Loss) on Disposition of Assets
LIFEVANTAGE CORP (LFVN) reported Gain (Loss) on Disposition of Assets of -$7.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-27
- LIFEVANTAGE CORP gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $0.00.
- LIFEVANTAGE CORP gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $0.00.
- LIFEVANTAGE CORP gain (loss) on disposition of assets for the quarter ending 2025-12-31 was -$3.00K.
- LIFEVANTAGE CORP gain (loss) on disposition of assets for the quarter ending 2025-09-30 was -$4.00K, a 200.00% decline year-over-year.
- LIFEVANTAGE CORP gain (loss) on disposition of assets for fiscal 2026 was -$7.00K, a 275.00% decline from fiscal 2025.
- LIFEVANTAGE CORP gain (loss) on disposition of assets for fiscal 2025 was $4.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $0.00 derived: sum of 2 quarters · filed 2026-08-27 | -$3.00K derived: sum of 3 quarters · filed 2026-08-27 | -$7.00K 10-K · filed 2026-08-27 |
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$3.00K derived: sum of 2 quarters · filed 2026-05-06 | -$7.00K 10-Q · filed 2026-05-06 | -$7.00K derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | -$7.00K 10-Q · filed 2026-02-04 | -$7.00K derived: sum of 3 quarters · filed 2026-08-27 | -$7.00K derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | -$4.00K 10-Q · filed 2025-11-04 | -$4.00K derived: sum of 2 quarters · filed 2026-08-27 | -$4.00K derived: sum of 3 quarters · filed 2026-08-27 | -$4.00K derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $0.00 derived: sum of 2 quarters · filed 2026-08-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-27 | $4.00K 10-K · filed 2026-08-27 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $4.00K 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $4.00K 10-Q · filed 2026-02-04 | ||
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-04 | |||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-05-06 | $0.00 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-05 | $0.00 10-Q · filed 2025-02-05 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-10-29 | |||
| 2023-03-31 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02 | -$24.00K 10-Q · filed 2024-05-02 | ||
| 2022-12-31 | -$7.00K 10-Q · filed 2024-01-30 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | $0.00 10-Q · filed 2023-05-04 | ||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |